JERRI SETHNA: Open Payments
NPI 1649236415 · THE WOODLANDS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,588 in 139 payments from 14 companies in 2025. Trend: 2023 $2,627 · 2024 $3,189 · 2025 $2,588
Food & beverage: $2,588
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 16 | $424 |
| Otsuka America Pharmaceutical, Inc. | 23 | $418 |
| Teva Pharmaceuticals USA, Inc. | 18 | $296 |
| Neurocrine BioSciences, Inc. | 16 | $284 |
| ABBVIE INC. | 14 | $249 |
| Vanda Pharmaceuticals Inc. | 13 | $244 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $164 |
| Lundbeck LLC | 12 | $143 |
| Validus Pharmaceuticals LLC | 5 | $113 |
| Axsome Therapeutics, Inc. | 4 | $86 |
Products named: COBENFY, REXULTI, INGREZZA, VRAYLAR, ABILIFY ASIMTUFII, AUSTEDO XR, CAPLYTA, HETLIOZ.
Industry payments across TX — which companies pay providers there.
